Simple jQuery Dropdowns

Browsing by Author Yoshinori Ito

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
1-Jan-2013Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2Shinzaburo Noguchi; Norikazu Masuda; Hiroji Iwata; Hirofumi Mukai; Jun Horiguchi; Puttisak Puttawibul; Vichien Srimuninnimit; Yutaka Tokuda; Katsumasa Kuroi; Hirotaka Iwase; Hideo Inaji; Shozo Ohsumi; Woo Chul Noh; Takahiro Nakayama; Shinji Ohno; Yoshiaki Rai; Byeong Woo Park; Ashok Panneerselvam; Mona El-Hashimy; Tetiana Taran; Tarek Sahmoud; Yoshinori Ito; Osaka University; Osaka National Hospital; Aichi Cancer Center Hospital and Research Institute; National Cancer Center Hospital East; Gunma University Hospital; Prince of Songkla University; Mahidol University; Tokai University; Tokyo Metropolitan Komagome Hospital; Kumamoto University; Osaka Medical Center for Cancer and Cardiovascular Diseases; National Shikoku Cancer Center Hospital; Korea Cancer Center Hospital; National Kyushu Cancer Center; Sagara Hospital; Yonsei University College of Medicine; Novartis Pharmaceuticals Corporation; Cancer Institute Hospital of Japan Foundation for Cancer Research
1-Jan-2013Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2Kathleen I. Pritchard; Howard A. Burris; Yoshinori Ito; Hope S. Rugo; Shaker Dakhil; Gabriel N. Hortobagyi; Mario Campone; Tibor Csöszi; José Baselga; Puttisak Puttawibul; Martine Piccart; Daniel Heng; Shinzaburo Noguchi; Vichien Srimuninnimit; Hugues Bourgeois; Antonio Gonzalez Martin; Karen Osborne; Ashok Panneerselvam; Tetiana Taran; Tarek Sahmoud; Michael Gnant; University of Toronto; Sarah Cannon Research Institute; Cancer Institute Hospital of Japan Foundation for Cancer Research; UCSF Helen Diller Family Comprehensive Cancer Center; Cancer Center of Kansas; University of Texas MD Anderson Cancer Center; Centre de Recherche en Cancérologie; Hetenyi Geza County Hospital; Memorial Sloan-Kettering Cancer Center; Prince of Songkla University; Institut Jules Bordet; University of Calgary; Osaka University; Mahidol University; Centre Jean Bernard; MD Anderson Cancer Center, Madrid; Novartis International AG; Novartis Pharmaceuticals Corporation; Medizinische Universitat Wien